http://thestreet.com/press-releases/celcuity-announces-breast-cancer-clinical-trial-collaboration-with-md-anderson-novartis-and-puma-biotechnology-to-study-new-drug-regimen-15597527
Celcuity Announces Breast Cancer Clinical Trial Collaboration With MD Anderson, Novartis, And Puma Biotechnology To Study New Drug Regimen - TheStreet
Celcuity Inc. (Nasdaq: CELC), a clinical stage biotechnology company utilizing its 3 rd generation companion diagnostics to identify new targeted therapeutic options for cancer patients, today announced a clinical trial collaboration with the MD Anderson...